1. Home
  2. KAPA vs RVP Comparison

KAPA vs RVP Comparison

Compare KAPA & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KAPA
  • RVP
  • Stock Information
  • Founded
  • KAPA 2013
  • RVP 1994
  • Country
  • KAPA United States
  • RVP United States
  • Employees
  • KAPA N/A
  • RVP N/A
  • Industry
  • KAPA
  • RVP Medical/Dental Instruments
  • Sector
  • KAPA
  • RVP Health Care
  • Exchange
  • KAPA NYSE
  • RVP Nasdaq
  • Market Cap
  • KAPA 21.3M
  • RVP 21.7M
  • IPO Year
  • KAPA 2024
  • RVP 2001
  • Fundamental
  • Price
  • KAPA $1.48
  • RVP $0.61
  • Analyst Decision
  • KAPA Strong Buy
  • RVP
  • Analyst Count
  • KAPA 1
  • RVP 0
  • Target Price
  • KAPA $9.00
  • RVP N/A
  • AVG Volume (30 Days)
  • KAPA 720.9K
  • RVP 65.4K
  • Earning Date
  • KAPA 11-14-2024
  • RVP 11-14-2024
  • Dividend Yield
  • KAPA N/A
  • RVP N/A
  • EPS Growth
  • KAPA N/A
  • RVP N/A
  • EPS
  • KAPA N/A
  • RVP N/A
  • Revenue
  • KAPA N/A
  • RVP $38,265,097.00
  • Revenue This Year
  • KAPA N/A
  • RVP N/A
  • Revenue Next Year
  • KAPA N/A
  • RVP N/A
  • P/E Ratio
  • KAPA N/A
  • RVP N/A
  • Revenue Growth
  • KAPA N/A
  • RVP N/A
  • 52 Week Low
  • KAPA $1.22
  • RVP $0.56
  • 52 Week High
  • KAPA $4.00
  • RVP $1.34
  • Technical
  • Relative Strength Index (RSI)
  • KAPA N/A
  • RVP 30.71
  • Support Level
  • KAPA N/A
  • RVP $0.56
  • Resistance Level
  • KAPA N/A
  • RVP $0.75
  • Average True Range (ATR)
  • KAPA 0.00
  • RVP 0.03
  • MACD
  • KAPA 0.00
  • RVP -0.01
  • Stochastic Oscillator
  • KAPA 0.00
  • RVP 26.74

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: